Costco, Toll: New Targets, Estimates
Also see: Oracle, Gen-Probe: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) --
STOCK COMMENTS / EPS CHANGES
Advanced Auto Parts
(AAP) - Get Free Report
price target cut at Citi to $65 from $70. 1Q below street, consumers increasingly price sensitive, Citigroup said. Maintain Hold rating.
Comcast
(CMCSA) - Get Free Report
added to Top Picks Live at Citi. Buybacks likely and strong financial flexibility, Citigroup said. Maintain Buy rating and $29 price target.
Costco
(COST) - Get Free Report
estimates lowered at Morgan Stanley. COST estimates were cut through 2013, Morgan Stanley said. Company is facing higher LIFO charges. Overweight rating and $90 price target.
Johnson & Johnson
(JNJ) - Get Free Report
numbers raised at UBS. Shares of JNJ now seen reaching $75, according to UBS. Estimates also increased, as the company can generate better organic growth in the coming quarters. Buy rating.
NetApp
(NTAP) - Get Free Report
estimates upped at Morgan Stanley through 2013. Business trends are improving. Equal-weight rating.
PSS World Medical
(PSSI)
numbers increased at Goldman. PSSI estimates were raised through 2014. Higher revenue is driving margin growth. Neutral rating and new $28 price target.
Polo Ralph Lauren
(RL) - Get Free Report
price target cut at Citi to $140 from $148. Fundamentals remain intact despite 4Q miss and new guidance, Citigroup said. Maintain Buy rating.
Sandridge Energy
(SD) - Get Free Report
estimates cut at UBS through 2012. Company is realizing lower production but has closed its funding gap. Neutral rating and $11.50 price target.
Semtech
(SMTC) - Get Free Report
estimates, target boosted at Goldman. Shares of SMTC now seen reaching $28, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Neutral rating.
Toll Brothers
(TOL) - Get Free Report
numbers raised at Goldman. Shares of TOL now seen reaching $20, according to Goldman Sachs. Estimates also increased, given better sentiment for the high-end of the housing market. Neutral rating.
Walgreen
(WAG)
cut from Conviction List at Goldman Sachs. Valuation call, as the stock is up 34% over the past year. $48 price target.
Watson Pharmaceuticals
(WPI)
price target boosted at Citi to $72 from $67. Specifar accretion substantially underestimated, Citigroup said. Maintain Buy rating.
This article was written by a staff member of TheStreet.
